American Vietnamese Biotech Incorporation Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	no data
Board average tenure	7.3yrs

Recent management updates

Recent updates

CEO

American Vietnamese Biotech Incorporation has no CEO, or we have no data on them.

Board Members

Name	Position	Tenure	Compensation	Ownership
Nguyen Trung	Director	no data	no data	no data
Hoang Oanh	Director	no data	no data	no data
Bach Ha	Chairman	no data	no data	no data
Thi Ha	Chairman of Control Committee	no data	no data	no data
Truong Tích	Director	no data	no data	no data
Le Ha	Director	no data	no data	no data
Dang Giang	Member of Control Committee	no data	no data	no data
Vu Ngat	Director	7.3yrs	no data	no data
Bui Hao	Director	no data	no data	no data
Dang Nhuong	Director	7.4yrs	no data	no data
Nguyen Huyen	Director	no data	no data	no data
Pham Tuy	Director	7.3yrs	no data	3.59% ₫ 15.5b

7.3yrs

Average Tenure

Experienced Board: AMV's board of directors are considered experienced (7.3 years average tenure).

American Vietnamese Biotech Incorporation Management

Management criteria checks 1/4

Key information

Recent management updates

No independent directors

No independent directors

Recent updates

Full year 2023 earnings released: EPS: ₫104 (vs ₫502 in FY 2022)

Third quarter 2023 earnings released: EPS: ₫37.00 (vs ₫32.95 in 3Q 2022)

Second quarter 2023 earnings released: EPS: ₫14.00 (vs ₫344 in 2Q 2022)

An unknown buyer entered into an agreement to acquire Bac Lieu High Techcare Clinic Joint Stock Company from American Vietnamese Biotech Incorporation (HNX:AMV) for VND 29.4 billion.

Investor sentiment improves as stock rises 18%

First quarter 2023 earnings released: EPS: ₫26.00 (vs ₫240 in 1Q 2022)

Investor sentiment improves as stock rises 17%

No independent directors

No independent directors

An unknown buyer acquired a 5.27% stake in American Vietnamese Biotech Incorporation (HNX : AMV) from Nguyen Thi Hien.

Full year 2020 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

American Vietnamese Biotech Incorporation (HNX:AMV) agreed to acquire 75% stake in Leopard Solutions Joint Stock Company for VND 6000 million.

Full year 2020 earnings released: EPS ₫2,056 (vs ₫4,137 in FY 2019)

Investor sentiment deteriorated over the past week

New 90-day low: ₫10,500

First Dividend Is ₫2,000 Per Share

New 90-day high: ₫18,100

American Vietnamese Biotech Incorporation announced that it has received VND 250 billion in funding

Nguyen Thi Hong Hai acquired 6.63% stake in American Vietnamese Biotech Incorporation (HNX:AMV)

New 90-day low - ₫15,500

CEO

Board Members

Average Tenure